Discover Community Create You

Loading publication...

Noodle always counts identifier-free feature events for service operation. With your permission, Google Analytics can also estimate audience and engagement. Search text, publication identifiers, cookies, IP addresses and browser fingerprints are never included in Noodle's first-party event counters.

Privacy details

Article

Prevalence of doravirine cross-resistance in HIV-infected adults who failed first-line ART in China, 2014-18.

The Journal of antimicrobial chemotherapy - 31 Mar 2022

Sun Zhuoqun, Lan Yun, Liang Shujia, Wang Jing, Ni Mingjian, Zhang Xia, Yu Fengting, Chen Meiling, Zhang Hanxi, Yan Liting, Cai Weiping, Lan Guanghua, Ma Ye, Zhang Fujie

Abstract excerpt

OBJECTIVES: To evaluate the prevalence and characteristics of doravirine resistance and cross-resistance in patients who failed first-line ART in China. METHODS: From 2014 to 2108, 4132 patients from five provinces were tested for drug resistance by genotypic resistance testing. Drug resistance mutations were assessed using the Stanford HIVdb algorithm Version 9.0. Sequences classified as having low-level,...

Read the complete abstract on PubMed

Topics

Share this publication in a Topic to start or enrich a Post.

Share to Anti-HIV Agents
Share to Drug Resistance, Viral

Methodology Data sources Editorial policy Privacy About Contact Helena Bioinformatics

Share to HIV Infections

Share to Prevalence

Share to Pyridones

Share to Reverse Transcriptase Inhibitors

Share to Triazoles

Source

Identifiers

PMID: 35134966
DOI: 10.1093/jac/dkac016

Provenance

PubMed metadata and Literature Corpus relationships. Corpus snapshot updated 7 Sept 2026.

Related research

Semantic proximity does not establish scientific evidence.

Research trail→

Click a neighbor to travelStep 1 · 12 closest

Prevalence of doravirine cross-resistance in HIV-infected adults who failed first-line ART in China, 2014-18.PMID 35134966Read ↗

Pretreatment drug resistance among people living with HIV from 2018 to 2022 in Guangzhou, China.Semantic proximity Read ↗

Prevalence of acquired drug resistance mutations in antiretroviral- experiencing subjects from 2012 to 2017 in Hunan Province of central South China.Semantic proximity Read ↗

Low prevalence of doravirine-associated resistance mutations among polish human immunodeficiency-1 (HIV-1)-infected patients.Semantic proximity Read ↗

Characterization of Pretreatment Drug Resistance among people living with HIV from 2018 to 2022 in Guangzhou, ChinaSemantic proximity Read ↗

In vitro cross-resistance to doravirine in a panel of HIV-1 clones harbouring multiple NNRTI resistance mutations.Semantic proximity Read ↗

Exploring disparities in HIV-1 pretreatment and acquired drug resistance in China from 2003 to 2022.Semantic proximity Read ↗

Changing Proportions of HIV-1 Subtypes and Transmitted Drug Resistance Among Newly Diagnosed HIV/AIDS Individuals — China, 2015 and 2018Semantic proximity Read ↗

Drug resistance and influencing factors in HIV-1-infected individuals under antiretroviral therapy in Guangxi, China.Semantic proximity Read ↗

Prevalence of doravirine-associated resistance mutations in HIV-1-infected antiretroviral-experienced patients from two large databases in France and Italy.Semantic proximity Read ↗

Brief communication: characteristics of primary drug resistance in newly diagnosed HIV-infected individuals in Ganzhou, China.Semantic proximity Read ↗

Distribution characteristics of drug resistance mutations of HIV CRF01_AE, CRF07_BC and CRF08_BC from patients under ART in Ganzhou, China.Semantic proximity Read ↗

Prevalence and transmission of HIV-1 drug resistance mutations among patients with treatment failure and newly diagnosed people in Liangshan Prefecture, China, in 2021–2023Semantic proximity Read ↗

⌁Select a neighboring publication to make it the new centre.